Clinical and serum metall minimum 1 year follow-up after hinged total knee revision arthroplasty

Clinical and serum metall minimum 1 year follow-up after hinged total knee revision arthroplasty - Genu X CoCr Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014572

Enrollment

Registered

2018-04-06

Start date

2018-04-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z96.65 T84.0

Interventions

Group 1: Patients that received a Genu X MK revision total knee arthroplasty at least 12 months prior to beginning of the study. Functional outcome will be assessed using the Knee Society Score, a pot

Eligibility

Sex/Gender

All

Age

40 Years to 95 Years

Inclusion criteria

Inclusion criteria: Patients that received a revision knee Arthoplasty using Genu X MK system between 01/2014 and 03/2017

Exclusion criteria

Exclusion criteria: •Patients not willing to participate.

Design outcomes

Primary

Measure	Time frame
Clinical Follow-up with range-of-motion and quality of life (Knee Society Score). Follow-up of chrome (normal value < 0.5 µg/l) und cobalt (normal value 0.5 – 3.9 µg/l) serum levels without a control group.	—

Countries

Germany

Contacts

Public ContactAntonio Klasan

Uniklinik Marburg, Zentrum für Orthopädie und Unfallchirurgie

klasan@med.uni-marburg.de06421/58-64715

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026